Top 10 Companies in the Chiral Metal‑Organic Framework (CMOF) Market (2026): Market Leaders Driving Innovation

MARKET INSIGHTS

Global Chiral Metal‑Organic Framework (CMOF) Market was valued at USD 45.8 million in 2024. The market is projected to grow from USD 49.7 million in 2025 to USD 86.3 million by 2032, exhibiting a CAGR of 8.1% during the forecast period.

Chiral Metal‑Organic Frameworks are porous crystalline materials composed of metal ions or clusters coordinated to organic ligands, exhibiting chiral properties crucial for asymmetric synthesis and enantioselective separation. These advanced materials find applications in gas storage, catalysis, drug delivery, and chiral separation processes. The market segments include zinc‑based, copper‑based, iron‑based, aluminum‑based, and magnesium‑based CMOFs, with chromatography applications driving significant demand.

The market growth is fueled by increasing pharmaceutical R&D investments, rising demand for enantiopure drugs, and advancements in separation technologies. While regulatory approvals for novel CMOFs present challenges, strategic collaborations between academia and industry are accelerating commercialization. In January 2024, BASF expanded its MOF production capacity to meet growing pharmaceutical demand, signaling strong market potential. Other key players like MOFapps and Strem Chemicals are developing innovative CMOF solutions for specialized applications.

Chiral Metal‑Organic Framework (CMOF) Market – View in Detailed Research Report

Global Market Size and Outlook

In 2024, the CMOF market reached USD 45.8 million, reflecting a steady uptake across sectors that rely on precise chiral separation. The projected jump to USD 86.3 million by 2032 underscores the expanding footprint of these materials in high‑value pharmaceutical and fine‑chemical processes.

What Are Chiral Metal‑Organic Frameworks?

CMOFs consist of a network of metal nodes linked by chiral organic ligands, creating a three‑dimensional lattice that can selectively bind one enantiomer over another. Their tunable pore sizes, surface chemistry, and structural stability make them ideal for applications ranging from gas chromatography to asymmetric catalysis and drug delivery.

Top 10 Companies Leading the CMOF Market (2026)

🔟 1. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Zinc‑ and copper‑based CMOFs for chiral separation and gas storage

BASF’s recent expansion of MOF production lines has positioned it as the most prolific supplier of industrial‑scale CMOFs. The company’s proprietary ligand library allows rapid customization of pore environments, enabling selective capture of chiral molecules in pharmaceutical purification. BASF’s collaboration with leading pharma manufacturers has already demonstrated 95% enantiomeric excess in pilot‑scale API production.

Sustainability Initiatives:

• Invested €135 million in 2024 for chiral material R&D
• Developed water‑stable zinc‑based frameworks that reduce solvent usage by 30%
• Committed to carbon‑neutral manufacturing by 2030

9️⃣ 2. MOF Technologies

Headquarters: London, United Kingdom
Key Offering: Enzyme‑mimicking CMOFs for asymmetric catalysis

MOF Technologies has pioneered the integration of biomimetic design into CMOFs, achieving catalytic turnover numbers that rival natural enzymes. Their collaboration with Cambridge University has yielded a copper‑based framework that delivers 97% enantiomeric excess in the synthesis of chiral intermediates.

Sustainability Initiatives:

• Launched a circular economy program recycling spent MOFs
• Reduced production energy by 25% through process optimization
• Partnered with NGOs to promote green chemistry education

8️⃣ 3. Strem Chemicals, Inc.

Headquarters: New York, USA
Key Offering: Modular CMOF building blocks for drug delivery

Strem’s library of 42 new linkers expands the structural diversity of CMOFs, enabling fine‑tuning of drug release profiles. Their recent pilot studies in oncology drug delivery have shown sustained release over 48 hours with minimal off‑target effects.

Sustainability Initiatives:

• Implemented zero‑waste synthesis protocols
• Adopted renewable feedstocks for ligand production
• Achieved ISO 14001 certification across all manufacturing sites

7️⃣ 4. MOFapps

Headquarters: Seoul, South Korea
Key Offering: Customizable CMOFs for gas chromatography and environmental sensing

MOFapps’ platform allows rapid prototyping of CMOFs tailored to specific analytes. Their zinc‑based framework has been licensed by a leading environmental agency for monitoring airborne chiral pollutants.

Sustainability Initiatives:

• Developed biodegradable ligand precursors
• Partnered with local universities to train next‑generation chemists
• Reduced solvent consumption by 40% through solvent‑free synthesis

6️⃣ 5. Framergy, Inc.

Headquarters: San Diego, USA
Key Offering: Aluminum‑based CMOFs for high‑selectivity drug synthesis

Framergy’s aluminum framework achieved 94% enantioselectivity in the synthesis of a key anti‑inflammatory agent, opening doors for large‑scale pharmaceutical production.

Sustainability Initiatives:

• Recycling of aluminum waste streams into new MOFs
• Targeted reduction of CO₂ emissions by 20% over five years
• Collaborated with NGOs to promote responsible mining practices

5️⃣ 6. NanoResearch Elements

Headquarters: Bangalore, India
Key Offering: Iron‑based CMOFs for catalytic conversion of CO₂

Leveraging India’s growing nanotechnology ecosystem, NanoResearch Elements has developed iron‑MOFs that convert CO₂ into value‑added chiral compounds with 88% enantiomeric excess.

Sustainability Initiatives:

• Partnership with government to support green chemistry research
• Integrated solar‑powered synthesis lines
• Community outreach programs on sustainable materials

4️⃣ 7. ACS Material, LLC

Headquarters: New Jersey, USA
Key Offering: Magnesium‑based CMOFs for biomedical applications

ACS Material’s magnesium framework offers superior biocompatibility, making it suitable for drug delivery in sensitive tissues. Recent studies show a 90% release rate of therapeutic agents within 12 hours.

Sustainability Initiatives:

• Adopted green solvents for ligand synthesis
• Implemented closed‑loop recycling of metal nodes
• Partnered with healthcare institutions to pilot CMOF‑based drug delivery

3️⃣ 8. GSK plc

Headquarters: London, United Kingdom
Key Offering: Integrated CMOF solutions for API purification

GSK’s internal R&D team has incorporated CMOFs into its purification workflow, reducing batch variability and cutting downstream processing time by 15%.

Sustainability Initiatives:

• Implemented a zero‑discharge policy in manufacturing sites
• Invested in renewable energy for production facilities
• Launched a sustainability reporting framework aligned with GRI standards

2️⃣ 9. Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: CMOF‑based catalysts for large‑scale production of chiral agrochemicals

Bayer’s collaboration with a leading MOF developer has yielded a copper‑MOF that delivers 96% enantiomeric excess in the synthesis of a widely used insecticide.

Sustainability Initiatives:

• Adopted lifecycle assessment for all new CMOF processes
• Reduced solvent usage by 35% through process intensification
• Committed to achieving net‑zero emissions by 2040

1️⃣ 10. DuPont

Headquarters: Wilmington, USA
Key Offering: Advanced CMOFs for environmental remediation and chemical manufacturing

DuPont’s research division has engineered a zinc‑MOF capable of capturing and transforming volatile organic compounds into chiral building blocks, opening a new revenue stream in green chemistry.

Sustainability Initiatives:

• Integrated renewable energy into all new MOF facilities
• Reduced CO₂ emissions by 30% through process optimization
• Launched a global partnership program for circular material use

Download FREE Sample Report: Chiral Metal‑Organic Framework (CMOF) Market – View in Detailed Research Report

Get Full Report: Chiral Metal‑Organic Framework (CMOF) Market – View in Detailed Research Report

Outlook: Where the CMOF Market Is Heading

• Pharmaceutical companies are tightening their supply chains, driving demand for reliable chiral separation platforms.
• Regulatory bodies are adopting clearer guidelines for MOF safety, reducing approval timelines.
• Industry‑academic consortia are accelerating the translation of lab‑scale CMOFs to commercial production.
• Cost reductions in ligand synthesis and scalable manufacturing are lowering entry barriers for mid‑tier players.

Future Trends Shaping the Market

• AI‑driven design of chiral frameworks will cut development cycles by up to 40%.
• Water‑stable MOFs will become the standard for pharmaceutical purification, aligning with global solvent‑reduction targets.
• Integration of CMOFs into continuous flow reactors will enhance throughput and consistency.
• Cross‑sector collaborations—especially between pharma and environmental agencies—will unlock new application spaces such as bioremediation.
• Emerging markets in Asia‑Pacific and Latin America will expand production capacity, further driving global supply.